Last updated: 5 months ago
Affimed N.V. 6-K Filing: Promising Results in NSCLC Trials & Strong Financial Outlook
Explore Affimed N.V.'s latest 6-K filing detailing significant clinical trial updates for AFM24, safety profile, efficacy results, and a robust cash position projected into 2025.